Cargando…

Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer

The suppression of ubiquitin-specific peptidase 17 (USP17) has previously been found to result in reduced tumorigenesis and invasion of non-small cell lung cancer (NSCLC) cells. However, the functions and underlying mechanisms of USP17 in NSCLC progression remain unclear. In the present study, cispl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shengchao, Xu, Zhenglang, Yuan, Jun, Chen, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286115/ https://www.ncbi.nlm.nih.gov/pubmed/32565935 http://dx.doi.org/10.3892/ol.2020.11568

Ejemplares similares

Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells
por: Zhang, Shengchao, et al.
Publicado: (2016)

Ubiquitin specific peptidases and prostate cancer
por: Guo, Yunfei, et al.
Publicado: (2023)

Ubiquitin-specific peptidase 22 promotes proliferation and metastasis in human colon cancer
por: Yuan, Xiao, et al.
Publicado: (2019)

Ubiquitin-specific peptidase 28 enhances STAT3 signaling and promotes cell growth in non-small-cell lung cancer
por: Li, Pengling, et al.
Publicado: (2019)

The role of ubiquitin-specific peptidases in cancer progression
por: Young, Ming-Jer, et al.
Publicado: (2019)

Expression and Role of Ubiquitin-Specific Peptidases in Osteoblasts
por: Hariri, Hadla, et al.
Publicado: (2021)

Ubiquitin‐specific peptidases: Players in bone metabolism
por: Shen, Jianlin, et al.
Publicado: (2023)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
por: Wu, Dong-ming, et al.
Publicado: (2019)

AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway
por: Liu, Yang, et al.
Publicado: (2020)

Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
Publicado: (2021)

Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
por: Chen, Shiyao, et al.
Publicado: (2021)

Activation of PI3K/Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer
por: Liu, Han, et al.
Publicado: (2023)

Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway
por: Wang, Yan, et al.
Publicado: (2013)

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route
por: Sun, Butong, et al.
Publicado: (2021)

Behavioral Characteristics of Ubiquitin-Specific Peptidase 46-Deficient Mice
por: Imai, Saki, et al.
Publicado: (2013)

Ubiquitin-specific peptidase 22 functions and its involvement in disease
por: Melo-Cardenas, Johanna, et al.
Publicado: (2016)

Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases
por: Pan, Kailing, et al.
Publicado: (2021)

The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates
por: Zheng, Jiahuan, et al.
Publicado: (2023)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
por: Lee, Min-Sik, et al.
Publicado: (2015)

Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma
por: Zhang, Na, et al.
Publicado: (2022)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis
por: Jeong, Chul-Ho
Publicado: (2015)

EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
por: Zheng, Yuanyuan, et al.
Publicado: (2023)

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
por: Sun, Dian-min, et al.
Publicado: (2018)

Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells
por: Yang, Lu, et al.
Publicado: (2020)

Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer
por: Lian, Jie, et al.
Publicado: (2020)

Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2
por: Du, Yanhua, et al.
Publicado: (2019)

Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression
por: Chauhan, Ravi, et al.
Publicado: (2023)

Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway
por: Zhang, Ying, et al.
Publicado: (2022)

Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway
por: Chen, Baishen, et al.
Publicado: (2019)

Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Zhaoxia, et al.
Publicado: (2020)

MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
por: Qiu, Chensheng, et al.
Publicado: (2020)

Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin
por: Tung, Chia-Hao, et al.
Publicado: (2023)

ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression
por: Chen, Hong, et al.
Publicado: (2021)

miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
por: Liu, Jiangang, et al.
Publicado: (2018)

HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer
por: Han, Shuyan, et al.
Publicado: (2023)

Author Correction: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
por: Lee, Min-Sik, et al.
Publicado: (2020)

Transcriptome profiling data reveals ubiquitin-specific peptidase 9 knockdown effects
por: Glaab, Enrico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ml2ld335mh146ej4mn0it5h1uj